HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Géraldine Mollet Selected Research

Nephrotic Syndrome (Syndrome, Nephrotic)

11/2021Neurological involvement in monogenic podocytopathies.
1/2020Sodium retention by uPA-plasmin-ENaC in nephrotic syndrome-Authors reply.
1/2020Generation of an induced pluripotent stem cell (iPSC) line (IMAGINi007) from a patient with steroid-resistant nephrotic syndrome carrying the homozygous p.R138Q mutation in the podocin-encoding NPHS2 gene.
12/2019Urokinase-type plasminogen activator contributes to amiloride-sensitive sodium retention in nephrotic range glomerular proteinuria in mice.
1/2018Endoplasmic reticulum-retained podocin mutants are massively degraded by the proteasome.
2/2014NPHS2 mutations in steroid-resistant nephrotic syndrome: a mutation update and the associated phenotypic spectrum.
10/2009Podocin inactivation in mature kidneys causes focal segmental glomerulosclerosis and nephrotic syndrome.
8/2008Maternal environment interacts with modifier genes to influence progression of nephrotic syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Géraldine Mollet Research Topics

Disease

8Nephrotic Syndrome (Syndrome, Nephrotic)
11/2021 - 08/2008
5Proteinuria
11/2021 - 08/2008
2Galloway Mowat syndrome
11/2021 - 01/2019
2Chronic Kidney Failure (Chronic Renal Failure)
01/2020 - 02/2014
2Albuminuria
12/2019 - 10/2009
2familial juvenile Nephronophthisis
03/2005 - 10/2002
1Microcephaly
11/2021
1Weight Loss (Weight Reduction)
12/2019
1Ascites
12/2019
1Renal Insufficiency (Renal Failure)
10/2009
1Sclerosis
10/2009
1Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal)
10/2009
1Hypertension (High Blood Pressure)
10/2009
1Hypercholesterolemia
10/2009
1Cystic Kidney Diseases (Cystic Kidney Disease)
03/2005
1Fibrosis (Cirrhosis)
03/2005
1Cysts
03/2005

Drug/Important Bio-Agent (IBA)

6NPHS2 proteinIBA
01/2020 - 08/2008
4Proteins (Proteins, Gene)FDA Link
11/2021 - 10/2002
2FibrinolysinFDA Link
01/2020 - 12/2019
2SodiumIBA
01/2020 - 12/2019
1SteroidsIBA
11/2021
1Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
12/2019
1PlasminogenIBA
12/2019
1ReninIBA
12/2019
1Amiloride (Midamor)FDA LinkGeneric
12/2019
1Peptide Hydrolases (Proteases)FDA Link
12/2019
1Messenger RNA (mRNA)IBA
01/2019
1Transfer RNA (tRNA)IBA
01/2019
14-phenylbutyric acid (Buphenyl)FDA Link
01/2016
1Lipocalin-2IBA
01/2016
1PotassiumIBA
08/2008
1CreatinineIBA
08/2008
1Urea (Carbamide)FDA LinkGeneric
08/2008
1TubulinIBA
03/2005

Therapy/Procedure

1Kidney Transplantation
02/2014